I agree that this site is using cookies. You can find further informations here.
X
Saglio, G.
249  results:
Search for persons X
?
1

S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB ..:

Pane, F. ; Castagnetti, F. ; Luciano, L....
HemaSphere.  6 (2022)  - p. 57-58 , 2022
Link: https://doi.org/10.1097/..
 
?
2

European LeukemiaNet 2020 recommendations for treating chro..:

Hochhaus, A. ; Baccarani, M. ; Silver, R. T....
Leukemia.  34 (2020)  4 - p. 966-984 , 2020
Link: https://doi.org/10.1038/..
 
?
3

Treatment-free remission following frontline nilotinib in p..:

Hochhaus, A ; Masszi, T ; Giles, F J...
Leukemia.  31 (2017)  7 - p. 1525-1531 , 2017
Link: https://doi.org/10.1038/..
 
?
4

Altered Erythropoiesis in Mouse Models of Type 3 Hemochroma..:

Pellegrino, R. M. ; Riondato, F. ; Ferbo, L....
BioMed Research International.  2017 (2017)  - p. 1-12 , 2017
Link: https://doi.org/10.1155/..
 
?
5

A phase II, multicentre trial of decitabine in higher-risk ..:

Santini, V ; Allione, B ; Zini, G...
Leukemia.  32 (2017)  2 - p. 413-418 , 2017
Link: https://doi.org/10.1038/..
 
?
6

Effects of Erythropoiesis-Stimulating Agents on Overall Sur..:

Messa, E. ; Gioia, D. ; Masiera, E....
Leukemia Research.  55 (2017)  - p. S58 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Long-term benefits and risks of frontline nilotinib vs imat..:

Hochhaus, A ; Saglio, G ; Hughes, T P...
Leukemia.  30 (2016)  5 - p. 1044-1054 , 2016
Link: https://doi.org/10.1038/..
 
?
8

Development and evaluation of a secondary reference panel f..:

Cross, N C P ; White, H E ; Ernst, T...
Leukemia.  30 (2016)  9 - p. 1844-1852 , 2016
Link: https://doi.org/10.1038/..
 
?
9

Frontline nilotinib in patients with chronic myeloid leukem..:

Hochhaus, A ; Rosti, G ; Cross, N C P...
Leukemia.  30 (2015)  1 - p. 57-64 , 2015
Link: https://doi.org/10.1038/..
 
?
10

147 IN VITRO CULTURE OF BM CELLS AND CYTC POLYMORPHISMS CAN..:

Cilloni, D. ; Podestà, M. ; Cossu, C....
Leukemia Research.  39 (2015)  - p. S74 , 2015
Link: https://doi.org/10.1016/..
 
?
11

Laboratory recommendations for scoring deep molecular respo..:

Cross, N C P ; White, H E ; Colomer, D...
Leukemia.  29 (2015)  5 - p. 999-1003 , 2015
Link: https://doi.org/10.1038/..
 
?
12

BCR-ABL1 mutation development during first-line treatment w..:

Hughes, T P ; Saglio, G ; Quintás-Cardama, A...
Leukemia.  29 (2015)  9 - p. 1832-1838 , 2015
Link: https://doi.org/10.1038/..
 
?
13

O-020 Erythropoietin alpha therapy in 1110 lower-risk MDS p..:

Messa, E. ; Gioia, D. ; Masiera, E....
Leukemia Research.  37 (2013)  - p. S18 , 2013
Link: https://doi.org/10.1016/..
 
?
14

Second Generation TKIs Can Induce Complete Molecular Respon..:

Fava, C. ; Rege-Cambrin, G. ; Busca, A....
Clinical Lymphoma Myeloma and Leukemia.  13 (2013)  - p. S367-S368 , 2013
Link: https://doi.org/10.1016/..
 
?
15

292 Morgana Haploinsufficiency Induces a Myeloproliferative..:

Di Savino, A. ; Morotti, A. ; Panuzzo, C....
European Journal of Cancer.  48 (2012)  - p. S71-S72 , 2012
Link: https://doi.org/10.1016/..
 
1-15